Licensing, Mergers & Acquisitions

Proprietary In-Licensing Capability

  • Geller Biopharm, in conjunction with the Frankel Group, offers a proprietary product for systematically identifying and acquiring novel compounds or companies utilizing a comprehensive array of resources.
  • Senior members of our team work in close conjunction with our clients, to conduct an initial broad scientific and commercial review of targeted therapeutic area(s), and build a list of appropriate companies and products for acquisition.
  • Leveraging our global relationships, Geller Biopharm helps guide internal due diligence, deal structure and execution with targeted compounds/companies.
Download our presentation
PDF

Get a digital copy of our PDF presentation

Download PDF